Innovative IT solutions to develop personalized cancer treatment.

Oslo Cancer Cluster and NCE Smart Energy Markets, together with European clusters in medicine and IT (see list below), was managing a Horizon 2020 EU project driving Personalized Medicine Innovation, called PERMIDES. The project lasted from September 2016 until August 2018.

PERMIDES matched small and medium enterprises (SMEs) from the IT and the biopharma sector for joint innovation projects.

Allocated funds were 45 million NOK, of which 34 million NOK were earmarked for SMEs in the clusters.

Please visit the official PERMIDES website for more information about this successful Horizon 2020-project.

  • Participants

    • Oslo Cancer Cluster S.A (NO)
    • NCE Smart Energy Markets, c/o Smart Innovation Østfold AS (NO)
    • Software-Cluster c/o CyberForum e.V. (DE)
    • Cluster für Individualisierte ImmunIntervention (Ci3) e.V. (DE)
    • intelligent views GmbH (DE)
    • NETSYNO Software GmbH (DE)
    • Oncotyrol – Center for Personalized Cancer Medicine GmbH (AT)
    • IT-Cluster – Business Upper Austria, OÖ Wirtschaftsagentur GmbH (AT)